Regulation of autophagy of prostate cancer cells by β-catenin signaling

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 926-932

  Lin, Rongkai ^a   Feng, Jiayu ^b   Dong, Shaoliang ^a   Pan, Runyang ^a   Zhuang, Huiqiang ^a   Ding, Zhenyu ^c  

^a No 180 Hospital of Chinese PLA   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Autophagy; Nitric oxide; Prostate cancer; Wnt; catenin

Indexed keywords

BETA CATENIN; NITRIC OXIDE; RAPAMYCIN;

ARTICLE; AUTOPHAGY; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; AUTOPHAGY; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NITRIC OXIDE; PROSTATIC NEOPLASMS; SIROLIMUS; WNT SIGNALING PATHWAY;

EID: 84921929686     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369749     Document Type: Article

References (23)

1. Saylor PJ: Prostate cancer: The androgen receptor remains front and centre. Nat Rev Clin Oncol 2013;10:126-128.
2. Alva A, Hussain M: The changing natural history of metastatic prostate cancer. Cancer J 2013;19:19-24.
3. Beltran H, Rubin MA: New strategies in prostate cancer: Translating genomics into the clinic. Clin Cancer Res 2013;19:517-523.
4. Xin L: Cells of origin for cancer: An updated view from prostate cancer. Oncogene 2013;32:3655-3663.
5. Huang S, Liao Q, Li L, Xin D: Pttg1 inhibits smad3 in prostate cancer cells to promote their proliferation. Tumour Biol 2014;35:6265-6270.
6. Xia Q, Li C, Bian P, Wang J, Dong S: Targeting smad3 for inhibiting prostate cancer metastasis. Tumour Biol 2014;35:8537-8541.
7. Green DR, Levine B: To be or not to be? How selective autophagy and cell death govern cell fate. Cell 2014;157:65-75.
8. Guo JY, Xia B, White E: Autophagy-mediated tumor promotion. Cell 2013;155:1216-1219.
9. White E: Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012;12:401-410.
10. Jia Z, Wang J, Wang W, Tian Y, Xiang Wei W, Chen P, Ma K, Zhou C: Autophagy eliminates cytoplasmic beta-catenin and nicd to promote the cardiac differentiation of p19cl6 cells. Cell Signal 2014;26:2299-2305.
11. Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou Y, Zhu J, Mi M: Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing wnt/beta-catenin signaling pathway. PLoS One 2014;9:e102535.
12. Liu D, Cui W, Liu B, Hu H, Liu J, Xie R, Yang X, Gu G, Zhang J, Zheng H: Atorvastatin protects vascular smooth muscle cells from tgf-beta1-stimulated calcification by inducing autophagy via suppression of the beta-catenin pathway. Cell Physiol Biochem 2014;33:129-141.
13. Petherick KJ, Williams AC, Lane JD, Ordonez-Moran P, Huelsken J, Collard TJ, Smartt HJ, Batson J, Malik K, Paraskeva C, Greenhough A: Autolysosomal beta-catenin degradation regulates wnt-autophagy-p62 crosstalk. EMBO J 2013;32:1903-1916.
14. Chang HW, Lee YS, Nam HY, Han MW, Kim HJ, Moon SY, Jeon H, Park JJ, Carey TE, Chang SE, Kim SW, Kim SY: Knockdown of beta-catenin controls both apoptotic and autophagic cell death through lkb1/ampk signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 2013;25:839-847.
15. Nguyen TM, Subramanian IV, Xiao X, Ghosh G, Nguyen P, Kelekar A, Ramakrishnan S: Endostatin induces autophagy in endothelial cells by modulating beclin 1 and beta-catenin levels. J Cell Mol Med 2009;13:3687-3698.
16. Clevers H, Nusse R: Wnt/beta-catenin signaling and disease. Cell 2012;149:1192-1205.
17. Huang SQ, Liao QJ, Wang XW, Xin DQ, Chen SX, Wu QJ, Ye G: Rnai-mediated knockdown of pituitary tumor-transforming gene-1 (pttg1) suppresses the proliferation and invasive potential of pc3 human prostate cancer cells. Braz J Med Biol Res 2012;45:995-1001.
18. Durocher Y, Chapdelaine A, Chevalier S: Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines pc3 and du145. Cancer Res 1989;49:4818-4823.
19. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L: Small molecule-mediated disruption of wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009;5:100-107.
20. Holland JD, Klaus A, Garratt AN, Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013;25:254-264.
21. Takebe N, Harris PJ, Warren RQ, Ivy SP: Targeting cancer stem cells by inhibiting wnt, notch, and hedgehog pathways. Nat Rev Clin Oncol 2011;8:97-106.
22. Amiel E, Everts B, Freitas TC, King IL, Curtis JD, Pearce EL, Pearce EJ: Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice. J Immunol 2012;189:2151-2158.
23. Sarkar S, Korolchuk VI, Renna M, Imarisio S, Fleming A, Williams A, Garcia-Arencibia M, Rose C, Luo S, Underwood BR, Kroemer G, O'Kane CJ, Rubinsztein DC: Complex inhibitory effects of nitric oxide on autophagy. Mol Cell 2011;43:19-32.